Zomedica Announces First Commercial Sale of Its Truforma® Platform
March 16, 2021 06:00 ET | Source: Zomedica Corp. Zomedica Corp. Ann Arbor, Michigan, UNITED STATES
ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA
® and officially entered commercialization.
“This is a momentous day for Zomedica, our shareholders, the veterinarians we serve, and the companion animals in their care. I would like to express my deepest gratitude to the many people at Zomedica who dedicated the past two years of their lives to achieving this critical milestone,” commented Robert Cohen, Zomedica’s Chief Executive Officer. “It is a credit to both our employees and to the stellar team with whom we have worked at
5GHz Wi-Fi UNII2c-3 bandBoost BAW Filter
rfglobalnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rfglobalnet.com Daily Mail and Mail on Sunday newspapers.
Zomedica Announces First Commercial Sale of Its Truforma® Platform
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.